Come up with a name for your new list and we'll add to it:
Admune Therapeutics was acquired by
Novartis on October 21, 2015.
Admune Therapeutics is a clinical-stage biotech company focused on the development and delivery of cytokine therapy drugs for the treatment of various cancers. The company's goal is to provide effecti…